Experience of New Brunswick ophthalmologists using intravitreal anti–vascular endothelial growth factor

Saved in:
Bibliographic Details
Published in:Canadian journal of ophthalmology 2015-10, Vol.50 (5), p.393-394
Main Authors: Giberson, Mariah, BSc, Taylor, Vicki, MD, FRCSC
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - economics
Angiogenesis Inhibitors - therapeutic use
Anti-Bacterial Agents - administration & dosage
Bevacizumab - economics
Bevacizumab - therapeutic use
Cost of Illness
Drug Costs
Health Care Surveys
Humans
Internal Medicine
Intravitreal Injections - statistics & numerical data
New Brunswick
Ophthalmology
Ophthalmology - statistics & numerical data
Practice Patterns, Physicians' - statistics & numerical data
Ranibizumab - economics
Ranibizumab - therapeutic use
Tomography, Optical Coherence - statistics & numerical data
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Wet Macular Degeneration - drug therapy
Wet Macular Degeneration - economics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0008-4182
1715-3360
DOI:10.1016/j.jcjo.2015.04.017